India's expert panel of Central Drugs Standard Control Organization(CDSCO) has recommended Bharat Biotech’s COVID-19 vaccine, Covaxin for second and third phase trials in children aged between two to eighteen years of age.

India's expert panel recommends Covaxin trials on 2-18 year-olds

covaxin-trials

Covaxin Trials, News on Covaxin Trials, stories on Covaxin Trials, articles on Covaxin Trials, Covaxin Trials stories at Wion, Covaxin Trials news, Covaxin Trials latest news

covaxin trials

India's expert panel recommends Covaxin trials on 2-18 year-olds